Carregant...
Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19
To evaluate the efficacy and safety of a new treatment for COVID-19 vs. standard care, certain key endpoints are related to the duration of a specific event, such as hospitalization, ICU stay, or receipt of supplemental oxygen. However, since patients may die in the hospital during study follow-up,...
Guardat en:
| Publicat a: | Contemp Clin Trials |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7486285/ https://ncbi.nlm.nih.gov/pubmed/32927092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2020.106145 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|